MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
23.73%
Quick Ratio
23.73%
Cash Ratio
3.41%
Debt to Asset Ratio
37.48%
Unit: Thousand (K) dollars
Assets Breakdown
    • Goodwill & intangible assets
    • Cash and cash equivalents
    • Trade receivables
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Non-controlling interests
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
347
1,168
4,360
6,923
Restricted cash
-
-
595
985
Short term investments
225
-
-
-
Property and equipment, held for sale
-
-
157
-
Trade receivables
327
-
-
-
Other current assets
1,517
1,875
463
954
Total current assets
2,416
3,043
5,575
8,862
Non-current restricted cash
-
-
-
161
Property and equipment, net
101
-
-
3,004
Right of use asset arising from operating lease and deposits
21
-
-
2,091
Goodwill & intangible assets
25,422
-
-
-
In-process research and development (ipr&d) asset
208
208
208
12,050
Funds in respect of employee rights upon terminations
18
-
-
-
Total non-current assets
25,770
-
208
17,306
Total assets
28,186
3,251
5,783
26,168
Short term bank credit
210
-
-
-
Trade account payables
908
720
3,120
1,508
Balance due to biomx ltd
1,254
1,254
-
-
Loans payable - related parties
887
-
-
-
Contingent consideration
1,695
-
-
-
Promissory notes
2,009
-
-
-
Warrant liability issued as consideration for subsidiary acquisition
2,082
-
-
-
Current portion of lease liabilities
8
-
1,436
1,296
Other account payables
1,127
473
1,823
2,422
Total current liabilities
10,180
2,447
6,379
5,226
Long term loans, net of current portion
247
-
-
-
Right of use liabilities arising from operating lease
13
-
-
5,287
Other liabilities
-
-
-
34
Severance pay liability
36
-
-
-
Warrants
87
1,685
706
5,135
Total non-current liabilities
383
1,685
706
10,456
Total liabilities
10,563
4,132
-
-
Preferred stock, 0.0001 par value authorized - 1,000,000 shares as of june 30, 2026 and december 31, 2025. issued and outstanding 51,598 as of june 30, 2026 and 147,512 shares as of december 31, 2025
6,512
18,617
18,617
18,617
Common stock, 0.0001 par value (common stock) authorized - 750,000,000 shares as of june 30, 2026 and december 31, 2025. issued and outstanding 12,590,640 and 1,593,703 as of june 30, 2026 and december 31, 2025, respectively
8
7
7
7
Receivables on account of shares
300
3,300
-
-
Additional paid-in capital
244,474
219,831
196,970
195,421
Accumulated deficit
-239,808
-236,036
-216,896
-203,559
Foreign currency translation adjustments
-21
-
-
-
Total companys stockholders equity (deficit)
10,865
-881
-1,302
10,486
Non-controlling interests
6,758
-
-
-
Total stockholders equity (deficit)
17,623
-
-
-
Total liabilities and stockholders equity (deficiency)
28,186
3,251
5,783
26,168
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Goodwill & intangibleassets$25,422K In-process research anddevelopment (ipr&d) asset$208K (-98.27%↓ Y/Y)Property and equipment,net$101K (-97.62%↓ Y/Y)Right of use assetarising from operating...$21K (-99.58%↓ Y/Y)Funds in respect ofemployee rights upon...$18K Other current assets$1,517K (-5.78%↓ Y/Y)Cash and cashequivalents$347K (-97.53%↓ Y/Y)Trade receivables$327K Short terminvestments$225K Total non-currentassets$25,770K (20.34%↑ Y/Y)Total current assets$2,416K (-85.48%↓ Y/Y)Total assets$28,186K (-25.92%↓ Y/Y)Total liabilities andstockholders equity...$28,186K (-25.92%↓ Y/Y)Total stockholdersequity (deficit)$17,623K Total liabilities$10,563K Total companysstockholders equity...$10,865K (-43.29%↓ Y/Y)Non-controlling interests$6,758K Total currentliabilities$10,180K (62.57%↑ Y/Y)Total non-currentliabilities$383K (-96.97%↓ Y/Y)Accumulated deficit-$239,808K (-23.36%↓ Y/Y)Receivables on account ofshares$300K Foreign currencytranslation adjustments-$21K Additional paid-in capital$244,474K (25.43%↑ Y/Y)Warrant liabilityissued as...$2,082K Promissory notes$2,009K Contingent consideration$1,695K Balance due to biomx ltd$1,254K Other accountpayables$1,127K (-60.47%↓ Y/Y)Trade accountpayables$908K (-58.31%↓ Y/Y)Loans payable -related parties$887K Short term bank credit$210K Current portion of leaseliabilities$8K (-99.35%↓ Y/Y)Long term loans, netof current portion$247K Warrants$87K (-98.02%↓ Y/Y)Severance pay liability$36K Right of useliabilities arising from...$13K (-99.84%↓ Y/Y)Preferred stock, 0.0001par value...$6,512K (-65.07%↓ Y/Y)Common stock, 0.0001par value (common...$8K (14.29%↑ Y/Y)

BiomX Inc. (PHGE)

BiomX Inc. (PHGE)